GeneDx (WGS) Short Interest Ratio & Short Volume $73.04 +0.23 (+0.32%) As of 01:13 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GeneDx Short Interest DataGeneDx (WGS) has a short interest of 3.47 million shares, representing 13.86% of the float (the number of shares available for trading by the public). This marks a -2.80% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.1, indicating that it would take 3.1 days of the average trading volume of 769,881 shares to cover all short positions.Current Short Interest3,470,000 sharesPrevious Short Interest3,570,000 sharesChange Vs. Previous Month-2.80%Dollar Volume Sold Short$220.73 millionShort Interest Ratio3.1 Days to CoverLast Record DateMay 15, 2025Outstanding Shares28,533,000 sharesFloat Size25,030,000 sharesShort Percent of Float13.86%Today's Trading Volume202,290 sharesAverage Trading Volume769,881 sharesToday's Volume Vs. Average26% Short Selling GeneDx? Sign up to receive the latest short interest report for GeneDx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartWGS Short Interest Over TimeWGS Days to Cover Over TimeWGS Percentage of Float Shorted Over Time GeneDx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20253,470,000 shares $220.73 million -2.8%13.9%3.1 $63.61 4/30/20253,570,000 shares $238.65 million +9.9%14.3%2.9 $66.85 4/15/20253,250,000 shares $332.22 million +17.8%13.0%3.2 $102.22 3/31/20252,760,000 shares $244.45 million +10.8%11.3%2.6 $88.57 3/15/20252,490,000 shares $245.19 million -1.2%10.2%2.5 $98.47 2/28/20252,520,000 shares $259.18 million -8.4%10.3%2.6 $102.85 2/15/20252,750,000 shares $209.96 million +28.5%11.4%3 $76.35 1/31/20252,140,000 shares $160.18 million No Change9.8%2.8 $74.85 1/15/20252,140,000 shares $154.96 million +2.9%9.7%3.1 $72.41 12/31/20242,080,000 shares $159.87 million -3.3%9.5%3.2 $76.86 Get the Latest News and Ratings for WGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GeneDx and its competitors with MarketBeat's FREE daily newsletter. 12/15/20242,150,000 shares $162.17 million -5.7%9.8%3.5 $75.43 11/30/20242,280,000 shares $178.73 million -2.6%10.4%3.7 $78.39 11/15/20242,340,000 shares $160.13 million -10.0%10.7%4 $68.43 10/31/20242,600,000 shares $212.39 million +8.3%12.8%4.8 $81.69 10/15/20242,400,000 shares $143.98 million +8.6%12.6%5 $59.99 9/30/20242,210,000 shares $93.79 million -0.5%11.6%4.8 $42.44 9/15/20242,220,000 shares $84.07 million +1.4%11.6%5.1 $37.87 8/31/20242,190,000 shares $69.95 million +6.8%11.8%5.3 $31.94 8/15/20242,050,000 shares $67.42 million +7.9%11.1%4.9 $32.89 7/31/20241,900,000 shares $62.17 million +17.3%10.9%4.1 $32.72 7/15/20241,620,000 shares $55.89 million +32.8%9.8%2.9 $34.50 6/30/20241,220,000 shares $31.89 million +8.9%7.4%2.3 $26.14 6/15/20241,120,000 shares $32.23 million +6.7%6.8%2.5 $28.78 5/31/20241,050,000 shares $20.59 million -10.3%6.4%2.3 $19.61 5/15/20241,170,000 shares $24.76 million +0.9%7.2%2.7 $21.16 4/30/20241,160,000 shares $19.80 million +8.4%7.1%3 $17.07 4/15/20241,070,000 shares $10.57 million -2.7%6.6%5 $9.88 3/31/20241,100,000 shares $10.04 million +4.8%6.8%4.2 $9.13 3/15/20241,050,000 shares $12.61 million -4.6%6.5%3.8 $12.01 2/29/20241,100,000 shares $8.97 million -9.1%6.8%3.7 $8.15 2/15/20241,210,000 shares $5.38 million +14.2%7.5%3.1 $4.45 1/31/20241,060,000 shares $4.08 million +6.9%6.9%2.7 $3.85 1/15/2024991,900 shares $3.63 million +44.7%6.4%2.5 $3.66 12/31/2023685,700 shares $1.89 million +9.4%4.4%2 $2.75 12/15/2023626,600 shares $1.52 million -16.5%4.0%2 $2.43 11/30/2023750,100 shares $1.31 million +15.2%4.8%2.8 $1.75 11/15/2023651,400 shares $840,306.00 -16.4%4.2%2.9 $1.29 10/31/2023779,100 shares $1.45 million +1.7%5.0%8.5 $1.86 10/15/2023765,900 shares $2.47 million +8.7%4.9%10.2 $3.23 9/30/2023704,500 shares $2.56 million -2.7%4.5%9.6 $3.64An AI run of epic proportions is only getting started (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 9/15/2023724,300 shares $3.17 million +2.6%4.7%7.8 $4.38 8/31/2023705,700 shares $3.14 million +1.4%4.2%5.4 $4.45 8/15/2023696,200 shares $3.57 million -2.3%4.2%4.3 $5.13 7/31/2023712,600 shares $5.28 million -0.8%4.3%4.1 $7.41 7/15/2023718,200 shares $4.83 million -6.9%4.3%3.9 $6.72 6/30/2023771,500 shares $4.60 million -18.7%4.6%4.4 $5.96 6/15/2023949,200 shares $6.95 million +18.8%5.7%5.8 $7.32 5/31/2023798,700 shares $6.01 million +7.8%4.9%5.1 $7.52 5/15/2023740,800 shares $5.32 million No Change4.6%5.6 $7.18 12/15/20224,770,000 shares $1.34 million -25.2%2.8%2.8 $0.28 11/30/20226,380,000 shares $2.64 million -35.9%3.9%4.5 $0.41 11/15/20229,950,000 shares $8.76 million -8.1%6.0%9.6 $0.88 10/31/202210,830,000 shares $11.15 million -1.5%6.7%8.8 $1.03 10/15/202210,990,000 shares $9.42 million -4.0%6.8%8.8 $0.86 9/30/202211,450,000 shares $10.05 million +1.2%7.0%8.7 $0.88 9/15/202211,320,000 shares $11.32 million -5.0%7.0%6.3 $1.00 8/31/202211,920,000 shares $12.16 million -1.2%7.4%5.6 $1.02 8/15/202212,060,000 shares $28.94 million -19.8%7.5%5.3 $2.40 7/31/202215,030,000 shares $24.35 million +10.3%9.4%6.9 $1.62 7/15/202213,630,000 shares $21.54 million +9.9%8.5%5.8 $1.58 6/30/202212,400,000 shares $15.62 million +18.3%7.7%5.3 $1.26 6/15/202210,480,000 shares $15.20 million +11.4%6.5%4.6 $1.45 5/31/20229,410,000 shares $19.20 million +22.7%5.9%5.3 $2.04 5/15/20227,670,000 shares $15.72 million +61.8%4.8%4.8 $2.05 4/30/20224,740,000 shares $10.19 million -1.9%4.0%3.3 $2.15 4/15/20224,830,000 shares $12.61 million -1.0%4.1%3.4 $2.61 3/31/20224,880,000 shares $14.98 million +4.3%4.1%2.9 $3.07 3/15/20224,680,000 shares $12.36 million -6.0%4.0%2.7 $2.64 2/28/20224,980,000 shares $17.38 million +8.5%4.3%2.9 $3.49 2/15/20224,590,000 shares $16.98 million -14.8%3.9%2.6 $3.70 1/31/20225,390,000 shares $18.43 million -13.5%5.2%3 $3.42 1/15/20226,230,000 shares $25.17 million -20.9%5.6%3.8 $4.04 12/31/20217,880,000 shares $35.14 million +5.5%7.1%6.3 $4.46 12/15/20217,470,000 shares $36.30 million -4.2%6.7%5.7 $4.86 11/30/20217,800,000 shares $52.03 million -2.0%7.0%5.7 $6.67 11/15/20217,960,000 shares $62.25 million -7.4%7.2%5.9 $7.82 10/29/20218,600,000 shares $69.40 million +0.2%7.7%5.9 $8.07 10/15/20218,580,000 shares $66.84 million -11.9%7.7%5.7 $7.79 9/30/20219,740,000 shares $73.93 million -2.1%8.7%6.5 $7.59 9/15/20219,950,000 shares $88.46 million +24.8%8.9%7.7 $8.89 8/31/20217,970,000 shares $75.72 million +57.8%7.1%7.1 $9.50 8/13/20215,050,000 shares $57.97 million No Change4.5%5.1 $11.48 WGS Short Interest - Frequently Asked Questions What is GeneDx's current short interest? Short interest is the volume of GeneDx shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 3,470,000 shares of WGS short. 13.86% of GeneDx's shares are currently sold short. Learn More on GeneDx's current short interest. What is a good short interest ratio for GeneDx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WGS shares currently have a short interest ratio of 3.0. Learn More on GeneDx's short interest ratio. Which institutional investors are shorting GeneDx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GeneDx: Jane Street Group LLC, Pentwater Capital Management LP, Cubist Systematic Strategies LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for GeneDx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.86% of GeneDx's floating shares are currently sold short. Is GeneDx's short interest increasing or decreasing? GeneDx saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 3,470,000 shares, a drop of 2.8% from the previous total of 3,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GeneDx's float size? GeneDx currently has issued a total of 28,533,000 shares. Some of GeneDx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GeneDx currently has a public float of 25,030,000 shares. How does GeneDx's short interest compare to its competitors? 13.86% of GeneDx's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to GeneDx: Option Care Health, Inc. (2.99%), Guardant Health, Inc. (7.81%), RadNet, Inc. (9.67%), BrightSpring Health Services, Inc. (13.76%), Sotera Health (9.01%), Surgery Partners, Inc. (12.60%), Privia Health Group, Inc. (3.30%), LifeStance Health Group, Inc. (8.03%), Veracyte, Inc. (6.81%), Addus HomeCare Co. (4.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short GeneDx stock? Short selling WGS is an investing strategy that aims to generate trading profit from GeneDx as its price is falling. WGS shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GeneDx? A short squeeze for GeneDx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of WGS, which in turn drives the price of the stock up even further. How often is GeneDx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WGS, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies OPCH Short Interest GH Short Interest RDNT Short Interest BTSG Short Interest SHC Short Interest SGRY Short Interest PRVA Short Interest LFST Short Interest VCYT Short Interest ADUS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WGS) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredFPV Drone Innovator Secures Major Defense ContractIn May, Ukraine launched Operation Spider Web - a 117-drone FPV swarm that devastated Russian fuel depots and ...The Tomorrow Investor | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WGS Stock Free WGS Stock Alerts